Table 1 Patient inclusion criteria

8130

Papillary, mild dysplasia, non-invasive (WHO-grade I)

Non-inv pap carcinoma LG

8131

Papillary, moderate dysplasia, non-invasive (WHO-grade II)

Non-inv pap carcinoma LG

8136

Papillary, not otherwise specified (NOS), non-invasive

Non-inv pap carcinoma LG

8132

Papillary, non-invasive, high-grade (WHO-grade III)

Non-inv pap carcinoma HG

8120

Non-papillary, mild dysplasia, non-invasive (WHO-grade I)

Dysplasia

8121

Non-papillary, moderate dysplasia, non-invasive (WHO-grade II)

Dysplasia

8126

Non-papillary, NOS, non-invasive

Dysplasia

8122

Non-papillary, non-invasive, high-grade (WHO-grade III)

Carcinoma in situ

8123

Non-papillary, NOS, invasive

Inv carcinoma

8124

Non-papillary, mild dysplasia, invasive (WHO-grade I)

Inv carcinoma

8125

Non-papillary,moderate dysplasia, invasive (WHO-grade II)

Inv carcinoma

8127

Non-papillary, invasive, high-grade (WHO-grade III)

Inv carcinoma

8133

Papillary, NOS, invasive

Inv carcinoma

8134

Papillary, mild dysplasia, invasive (WHO-grade I)

Inv carcinoma

8135

Papillary, moderate dysplasia, invasive (WHO-grade II)

Inv carcinoma

8137

Papillary, invasive, high-grade (WHO-grade III)

Inv carcinoma

80103^a

Carcinoma in situ, NOS

Inv carcinoma

80203^a

Carcinoma, undifferentiated, invasive, NOS

Inv carcinoma

812031^a

Highly differentiated, invasive, G1, low-grade

Inv carcinoma

812032^a

Moderately differentiated, invasive, G2, low-grade

Inv carcinoma

812033^a

Poorly differentiated, invasive, G3, high-grade

Inv carcinoma

812034^a

Undifferentiated, invasive, G4, high-grade

Inv carcinoma

812039^a

NOS, invasive

Inv carcinoma

Total number of individuals